Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
The American Journal of Medicine
|
July 11, 2006
Treatment of depression in patients with coronary heart disease
W Victor R Vieweg, Demetrios A Julius, Antony Fernandez, et al.
The American Journal of Medicine
|
August 12, 2008
Psychotropic drug considerations in depressed patients with metabolic disturbances
W Victor R Vieweg, James R Levy, Sonja K Fredrickson, et al.
Psychopharmacology
|
July 2, 2013
Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports
W Victor R Vieweg, Mehrul Hasnain, Jules C Hancox, et al.
Therapeutic Advances in Psychopharmacology
|
October 30, 2013
Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problem
W Victor R Vieweg, Mehrul Hasnain, Robert H Howland, et al.
The American Journal of Psychiatry
|
March 3, 2020
QTc Prolongation and Psychotropic Medications
Margo C Funk, Scott R Beach, Jolene R Bostwick, et al.
Therapeutic Advances in Drug Safety
|
August 13, 2014
Selective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reports
Christopher Kogut, Ericka Breden Crouse, W Victor R Vieweg, et al.
Journal of Clinical Psychopharmacology
|
December 19, 2013
Quetiapine and the need for a thorough QT/QTc study
Mehrul Hasnain, W Victor R Vieweg, Robert H Howland, et al.
Therapeutic Advances in Psychopharmacology
|
July 25, 2014
Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports
Mehrul Hasnain, W Victor R Vieweg, Robert H Howland, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments
Sidney H Kennedy, Raymond W Lam, Roger S McIntyre, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
The American Journal of Medicine
|
July 11, 2006
Treatment of depression in patients with coronary heart disease
W Victor R Vieweg, Demetrios A Julius, Antony Fernandez, et al.
The American Journal of Medicine
|
August 12, 2008
Psychotropic drug considerations in depressed patients with metabolic disturbances
W Victor R Vieweg, James R Levy, Sonja K Fredrickson, et al.
Psychopharmacology
|
July 2, 2013
Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports
W Victor R Vieweg, Mehrul Hasnain, Jules C Hancox, et al.
Therapeutic Advances in Psychopharmacology
|
October 30, 2013
Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problem
W Victor R Vieweg, Mehrul Hasnain, Robert H Howland, et al.
The American Journal of Psychiatry
|
March 3, 2020
QTc Prolongation and Psychotropic Medications
Margo C Funk, Scott R Beach, Jolene R Bostwick, et al.
Therapeutic Advances in Drug Safety
|
August 13, 2014
Selective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reports
Christopher Kogut, Ericka Breden Crouse, W Victor R Vieweg, et al.
Journal of Clinical Psychopharmacology
|
December 19, 2013
Quetiapine and the need for a thorough QT/QTc study
Mehrul Hasnain, W Victor R Vieweg, Robert H Howland, et al.
Therapeutic Advances in Psychopharmacology
|
July 25, 2014
Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports
Mehrul Hasnain, W Victor R Vieweg, Robert H Howland, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments
Sidney H Kennedy, Raymond W Lam, Roger S McIntyre, et al.
Page
of 5